• Educational resources
  • Events
  • Expert Panel
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region
Dermatology

Translating the Science of CSU: From Pathogenesis to Patient Outcomes

Join Drs. Michihiro Hide, Marta Ferrrer, and Ana M. Giménez-Arnau as they discuss chronic spontaneous urticaria (CSU) and highlight the unmet needs, treatment challenges, and emerging therapies.
Michihiro Hide
Marta Ferrer
Ana Maria Giménez-Arnau
MD, PhD
Michihiro Hide +2 more
GUF PNG
Past event
4December2024

Symposium Details

December 4

Translating the Science of CSU: From Pathogenesis to Patient Outcomes

Join Drs. Michihiro Hide, Marta Ferrrer, and Ana M. Giménez-Arnau as they discuss chronic spontaneous urticaria (CSU) and highlight the unmet needs, treatment challenges, and emerging therapies.

Agenda

Learning objectives

  • Understand the unmet needs and the importance of achieving and maintaining disease control in CSU
  • Discuss the latest advancements in CSU pathophysiology, including mast cell activation pathways with demonstrated clinical relevance
  • Describe the latest data on CSU therapeutics and the potential future for CSU management
Tags
symposium
MAT-US-2412088 v1.0 - P Exp Date: 11/24/2025

Speakers

Dermatology
MD, PhD

Michihiro Hide

Hiroshima City Hiroshima Citizens Hospital

Allergy/Immunology
MD, PhD

Marta Ferrer

Head of the Department of Allergy at Navarra University Hospital, Pamplona, Spain

Dermatology
MD, PhD

Ana Maria Giménez-Arnau

Associate Professor of Dermatology | Autonomous University and Pompeu Fabra University, Barcelona, Spain